[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @EgidiusLambrech E Lambrechts E Lambrechts posts on X about $gmab, $abbv, checkpoint, approved the most. They currently have XXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::404367469/interactions)  - X Week XXX +281% - X Month XXX -XX% - X Months XXXXXX -XX% - X Year XXXXXX +25% ### Mentions: XX [#](/creator/twitter::404367469/posts_active)  ### Followers: XXX [#](/creator/twitter::404367469/followers)  - X Week XXX +3.20% - X Month XXX +3.80% - X Months XXX +6.90% - X Year XXX -XX% ### CreatorRank: undefined [#](/creator/twitter::404367469/influencer_rank)  ### Social Influence [#](/creator/twitter::404367469/influence) --- **Social category influence** [stocks](/list/stocks) **Social topic influence** [$gmab](/topic/$gmab), [$abbv](/topic/$abbv), [checkpoint](/topic/checkpoint), [approved](/topic/approved), [$jnj](/topic/$jnj), [$halo](/topic/$halo), [$fro](/topic/$fro) **Top assets mentioned** [AbbVie Inc (ABBV)](/topic/$abbv) [Johnson & Johnson (JNJ)](/topic/$jnj) [Halozyme Therapeutics, Inc. (HALO)](/topic/$halo) [Frontline Ltd. (FRO)](/topic/$fro) ### Top Social Posts [#](/creator/twitter::404367469/posts) --- Top posts by engagements in the last XX hours "New #Genmab trial: Study of the Effectiveness and Safety of #Acasunlimab Alone and With Pembrolizumab to Treat Advanced #Melanoma of the Skin That Has Returned After Treatment With an Approved Checkpoint Inhibitor Therapy (ABBIL1TY MELANOMA-07) $GMAB"  [@EgidiusLambrech](/creator/x/EgidiusLambrech) on [X](/post/tweet/1925555019371192368) 2025-05-22 14:11:06 UTC XXX followers, XXX engagements "@BertrandBio it is exactly one of the points Genmab's Jan van de Winkel made when promoting Hexabody-CD38 in one of his conference calls; wouldn't it be fun if JNJ were to reconsider their decision to opt-out of Hexa-CD38 😂"  [@EgidiusLambrech](/creator/x/EgidiusLambrech) on [X](/post/tweet/1922701797832937685) 2025-05-14 17:13:25 UTC XXX followers, XXX engagements "#DARZALEX (daratumumab) receives the first positive #CHMP opinion for patients with high-risk #smouldering multiple myeloma $JNJ $GMAB #Genmab $HALO #EMA"  [@EgidiusLambrech](/creator/x/EgidiusLambrech) on [X](/post/tweet/1936011823196553444) 2025-06-20 10:42:42 UTC XXX followers, XXX engagements "#Acasunlimab + PD-1 Blockade: Combining Forces to Boost Anti-Tumor Immunotherapy @Genmab $GMAB #GEN1046 #DuoBody-PD-L1x4-1BB"  [@EgidiusLambrech](/creator/x/EgidiusLambrech) on [X](/post/tweet/1922546897463435448) 2025-05-14 06:57:54 UTC XXX followers, XXX engagements "Phase III trial of #rinatabart sesutecan in platinum-resistant ovarian cancer #Genmab $GMAB Rina-S @AngelesSecord"  [@EgidiusLambrech](/creator/x/EgidiusLambrech) on [X](/post/tweet/1942501543065878884) 2025-07-08 08:30:32 UTC XXX followers, XXX engagements "#Genmab $GMAB #AbbVie $ABBV #Epcoritamab #Epkinly #ICML2025"  [@EgidiusLambrech](/creator/x/EgidiusLambrech) on [X](/post/tweet/1935633294336594402) 2025-06-19 09:38:34 UTC XXX followers, 1155 engagements "#Acasunlimab an Fc-inert PD-L14-1BB bispecific antibody combined with PD-1 blockade potentiates antitumor immunity via complementary immune modulatory effects $GMAB #Genmab #DuoBody #GEN1046"  [@EgidiusLambrech](/creator/x/EgidiusLambrech) on [X](/post/tweet/1911775214494511503) 2025-04-14 13:35:04 UTC XXX followers, XXX engagements "Results from EPCORE NHL-2 trial of #epcoritamab + R-CHOP for previously untreated DLBCL #Genmab $GMAB #AbbVie $ABBV #Epkinly #ICML2025"  [@EgidiusLambrech](/creator/x/EgidiusLambrech) on [X](/post/tweet/1935625131826745706) 2025-06-19 09:06:08 UTC XXX followers, 1119 engagements "FDA rejects new indication for Columvi Roche Genentech $ABBV $GMAB AbbVie Genmab #Epkinly #Epcoritamab via @onclive"  [@EgidiusLambrech](/creator/x/EgidiusLambrech) on [X](/post/tweet/1947207891301073191) 2025-07-21 08:11:53 UTC XXX followers, XXX engagements "#Genmab $GMAB #AbbVie $ABBV #Epcoritamab #Epkinly #ICML2025"  [@EgidiusLambrech](/creator/x/EgidiusLambrech) on [X](/post/tweet/1935633437366645173) 2025-06-19 09:39:08 UTC XXX followers, 1108 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
E Lambrechts posts on X about $gmab, $abbv, checkpoint, approved the most. They currently have XXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence stocks
Social topic influence $gmab, $abbv, checkpoint, approved, $jnj, $halo, $fro
Top assets mentioned AbbVie Inc (ABBV) Johnson & Johnson (JNJ) Halozyme Therapeutics, Inc. (HALO) Frontline Ltd. (FRO)
Top posts by engagements in the last XX hours
"New #Genmab trial: Study of the Effectiveness and Safety of #Acasunlimab Alone and With Pembrolizumab to Treat Advanced #Melanoma of the Skin That Has Returned After Treatment With an Approved Checkpoint Inhibitor Therapy (ABBIL1TY MELANOMA-07) $GMAB" @EgidiusLambrech on X 2025-05-22 14:11:06 UTC XXX followers, XXX engagements
"@BertrandBio it is exactly one of the points Genmab's Jan van de Winkel made when promoting Hexabody-CD38 in one of his conference calls; wouldn't it be fun if JNJ were to reconsider their decision to opt-out of Hexa-CD38 😂" @EgidiusLambrech on X 2025-05-14 17:13:25 UTC XXX followers, XXX engagements
"#DARZALEX (daratumumab) receives the first positive #CHMP opinion for patients with high-risk #smouldering multiple myeloma $JNJ $GMAB #Genmab $HALO #EMA" @EgidiusLambrech on X 2025-06-20 10:42:42 UTC XXX followers, XXX engagements
"#Acasunlimab + PD-1 Blockade: Combining Forces to Boost Anti-Tumor Immunotherapy @Genmab $GMAB #GEN1046 #DuoBody-PD-L1x4-1BB" @EgidiusLambrech on X 2025-05-14 06:57:54 UTC XXX followers, XXX engagements
"Phase III trial of #rinatabart sesutecan in platinum-resistant ovarian cancer #Genmab $GMAB Rina-S @AngelesSecord" @EgidiusLambrech on X 2025-07-08 08:30:32 UTC XXX followers, XXX engagements
"#Genmab $GMAB #AbbVie $ABBV #Epcoritamab #Epkinly #ICML2025" @EgidiusLambrech on X 2025-06-19 09:38:34 UTC XXX followers, 1155 engagements
"#Acasunlimab an Fc-inert PD-L14-1BB bispecific antibody combined with PD-1 blockade potentiates antitumor immunity via complementary immune modulatory effects $GMAB #Genmab #DuoBody #GEN1046" @EgidiusLambrech on X 2025-04-14 13:35:04 UTC XXX followers, XXX engagements
"Results from EPCORE NHL-2 trial of #epcoritamab + R-CHOP for previously untreated DLBCL #Genmab $GMAB #AbbVie $ABBV #Epkinly #ICML2025" @EgidiusLambrech on X 2025-06-19 09:06:08 UTC XXX followers, 1119 engagements
"FDA rejects new indication for Columvi Roche Genentech $ABBV $GMAB AbbVie Genmab #Epkinly #Epcoritamab via @onclive" @EgidiusLambrech on X 2025-07-21 08:11:53 UTC XXX followers, XXX engagements
"#Genmab $GMAB #AbbVie $ABBV #Epcoritamab #Epkinly #ICML2025" @EgidiusLambrech on X 2025-06-19 09:39:08 UTC XXX followers, 1108 engagements
/creator/x::EgidiusLambrech